Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPC 083 in HIV-1-infected patients failing NNRTI treatment
NCT00007449Phase 2Unknown
- Sponsor
- DuPont
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DPC 083 in human immunodeficiency virus infection (HIV), sponsored by DuPont. Status: unknown.
02
Drugs
DPC 083
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00007449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007449.